Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal

Vet Microbiol. 2018 Jul:220:47-52. doi: 10.1016/j.vetmic.2018.05.003. Epub 2018 May 4.

Abstract

The yeast Malassezia pachydermatis is a component of the microbiota of dogs and cats, however it can cause otitis and seborrheic dermatitis in these animals. The objective of this study was to determine the antifungal susceptibility, and evaluate virulence and pathogenicity of 25 M. pachydermatis strains from animals. Susceptibility to ketoconazole, fluconazole, itraconazole, voriconazole, terbinafine, and amphotericin B was evaluated by broth microdilution assay. In addition, biofilm-forming ability, protease, phospholipase, hemolysin and melanin production and adhesion to epithelial cells by this yeast species were assessed. Finally, strain pathogenicity was investigated using the nematode Caenorhabditis elegans. Concerning the planktonic susceptibility, minimum inhibitory concentrations varied from <0.03 to>64 μg/mL for azole derivatives, 1 to >16 μg/mL for amphotericin B and 0.03 to 0.25 μg/mL for terbinafine. All strains were classified as strong biofilm producers, and ketoconazole, fluconazole and amphotericin B presented the best inhibitory effect against mature biofilms. All fungal isolates produced proteases, whereas 14/25 strains were positive for phospholipase production. Hemolytic activity was not observed and 18/25 strains showed dark pigmentation in the presence of L-DOPA. Regarding adhesion to epithelial cells, a low adhesion rate was observed in 10/12 evaluated strains. C. elegans mortality rate reached 95.9% after 96 h of exposure of the worms to M. pachydermatis. This yeast species produces important virulence factors and presents high pathogenicity, corroborating its clinical importance.

Keywords: Antifungal susceptibility; Malassezia pachydermatis; Pathogenicity; Virulence attributes.

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Bacterial Adhesion
  • Biofilms / drug effects
  • Caenorhabditis elegans
  • Cat Diseases / microbiology
  • Cats
  • Dermatomycoses / microbiology
  • Dermatomycoses / veterinary*
  • Dog Diseases / microbiology
  • Dogs
  • Epithelial Cells / microbiology
  • Fluconazole / pharmacology
  • Foxes / microbiology
  • Itraconazole / pharmacology
  • Ketoconazole / pharmacology
  • Malassezia / drug effects*
  • Malassezia / enzymology
  • Malassezia / isolation & purification
  • Malassezia / pathogenicity*
  • Microbial Sensitivity Tests / methods
  • Peptide Hydrolases / biosynthesis
  • Phospholipases / biosynthesis
  • Virulence

Substances

  • Antifungal Agents
  • Itraconazole
  • Fluconazole
  • Phospholipases
  • Peptide Hydrolases
  • Ketoconazole